ClinicalTrials.gg
RecruitingNCT06885203Updated Aug 12, 2026

Social and Environmental Determinants of Breast Cancer Survivorship: the Black Breast Cancer Survivor's Intervention (BBCSI)

An interventional study of Black Breast Cancer Survivor's Intervention in Breast Cancer, sponsored by M.D. Anderson Cancer Center. Recruiting at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-12.

Sponsored by M.D. Anderson Cancer Center · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Aug 2025; still recruiting 1 year 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 230 studies in Breast Neoplasms by M.D. Anderson Cancer Center — 29 open to participants now, 71 under way, 3 of them phase 3. Breast Neoplasms · M.D. Anderson Cancer Center.

Planned enrollment
71st of 177
56 · median 40
Started
2025
with 7 others
No phase
61 of 230
10 open now
Primary completion
2027-08
later than 31 of 70 live
Registered
217th of 230
by date

Among the 230 studies in Breast Neoplasms by M.D. Anderson Cancer Center, this one is the 71st largest by planned enrollment of the 177 interventional ones that give a count, is one of 8 that started in 2025, is one of 61 with no phase, reaches primary completion later than 31 of the 70 other live ones, and was the 217th registered.

Breast Neoplasms

14,855 studies on the registry are indexed under Breast Neoplasms; 3,321 are open to participants now.

Browse Breast Neoplasms studies →

Open to participants now

29 of the 230 studies in Breast Neoplasms by M.D. Anderson Cancer Center are open now, in 1 country. Recruiting first, the newest first:

23 more — sign in →

By country, each count listing its studies:

All 29 open studies →

Who these studies take

Of the 2,403 Breast Neoplasms studies recruiting now, 1,574 (66%) set no upper age limit and 591 (25%) stop at 75 or younger; 103 take children under 18; 215 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 230 studies in Breast Neoplasms by M.D. Anderson Cancer Center, or all of them as a file.
02

Study summary

The goal of this research study is to learn about the effects of the BBCSI course on the quality of life of Black breast cancer survivors.

A community-based and peer-led Black Breast Cancer Survivor's Intervention (BBCSI) course has been developed to help improve the quality of life of Black breast cancer survivors.

Read the detailed description

Primary Objectives:

Develop a prototype of the BBCSI curriculum and assess satisfaction of the intervention.

Determine the preliminary efficacy of the BBCSI.

Evaluate fidelity, feasibility, acceptability, barriers, and facilitators of the BBCSI.

03

Conditions studied

  • Breast Cancer

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

Master Trainers:

To be eligible to participate in this study, an individual must meet all the following criteria:

  1. Adult women aged 18 years and older
  2. confirmed stage 0-III breast cancer
  3. No evidence of disease
  4. Self-identify as Black
  5. Able to communicate in English

Participants:

To be eligible to participate in this study, an individual must meet all the following criteria:

  1. Adult women aged 18 years and older
  2. Histologically confirmed stage 0-III breast cancer
  3. No evidence of metastatic disease
  4. Self-identify as Black
  5. Able to communicate in English

Community Interventionists:

To be eligible to participate in this study, an individual must meet all the following criteria:

  1. Adult women aged 18 years and older
  2. Histologically confirmed stage 0-III breast cancer
  3. No evidence of metastatic disease
  4. Self-identify as Black
  5. Former study participants that have completed the intervention
  6. Able to communicate in English

General Exclusion Criteria:

  1. Men or woman below 18 years of age
  2. Does not have a histologically confirmed breast cancer
  3. There's evidence of metastatic disease
  4. Does not self-identify as Black
  5. Unable to communicate in English

Additional Exclusion Criteria - Community Interventionists

1. Has not previously participated in and completed the study intervention as a participant

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Histologically or cytologically confirmed

The diagnosis was confirmed by looking at a sample under a microscope: tissue from a biopsy or surgery (histology), or cells from a fluid or needle sample (cytology).

Your pathology report is the document that shows this.

Metastases

Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
56 participants (estimated)

Study arms

  • Experimental
    Immediate Intervention Group

    Participants will be recruited through our Community Based Organizations (CBOs) and other community collaborator networks.

    Behavioral: Black Breast Cancer Survivor's Intervention

  • Experimental
    Wait-List (start in week 7)

    Participants will be recruited through our Community Based Organizations (CBOs) and other community collaborator networks.

    Behavioral: Black Breast Cancer Survivor's Intervention

Interventions

  • BehavioralBlack Breast Cancer Survivor's Intervention

    Participants will complete the BBCSI course (1-hour virtual sessions every week for 6 weeks), answer questionnaires before and after the course, and provide urine samples.

06

What researchers measure

Primary outcomes

  1. Safety and Adverse Events (AEs)

    Safety and Adverse Events (AEs)

    Time frame: Time Frame: Through study completion; an average of 1 year

07

Study locations

1 of 1 sites recruiting
08

References and documents

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2025 (actual). Primary completion is estimated for Aug 2027, 24 months after the start.

Of 2,673 non-industry interventional studies with no phase under Breast Neoplasms, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 66. This study's planned 24 months is below that.

Counting every sponsor, half of 2,783 studies reached it within 33 months; a quarter within 15 and three quarters within 66.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 18, 2025
First posted
Mar 20, 2025
StartActual
Aug 27, 2025
Primary completionEst.
Aug 31, 2027
CompletionEst.
Aug 31, 2029
Last update
Aug 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06885203
Responsible party
Sponsor
First posted
Mar 20, 2025
Start date
Aug 27, 2025
Primary completion
Aug 31, 2027 (estimated)
Completion
Aug 31, 2029 (estimated)
Last update
Aug 12, 2026

Study contacts

Dede Teteh-Brooks, DRPH
Contact
dkteteh@mdanderson.org
713-563-3493
Dede Teteh-Brooks, DRPH
principal investigator · M.D. Anderson Cancer Center

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion